Immediate Procedures Segment to Lead Market During 2021–2028
According to our new research study on “Breast Reconstruction Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technology, Type, Placement, and Procedure,” the market is expected to reach US$ 945.27 million by 2028 from US$ 593.61 million in 2020; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the high prevalence of breast cancer, and new product launches and FDA approvals. However, low awareness regarding reimbursement policies hinders the market growth.
Based on procedure, the breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures. In 2020, the immediate procedures segment held the largest share of the market, and the market for the same segment is expected to grow at the fastest rate during the coming years. Immediate breast reconstruction after mastectomy is an integral part of the complete management of breast cancer. Determining the risk of postmastectomy irradiation prior to definitive resection and reconstructive operations may reduce complications and improve aesthetic outcomes by guiding surgical decision making.
Allergan Plc; Mentor Worldwide LLC (Subsidiary of Johnson & Johnson); Sientra Inc.; Gc Aesthetics Plc; Polytech Health & Aesthetics Gmbh; Hansbiomed Co. Ltd.; Ideal Implant Incorporated; Guangzhou Wanhe Plastic Materials Co., Ltd.; Establishment Labs S.A.; and Groupe Sebbin SAS are among the leading companies operating in the breast reconstruction market.
The report segments the Breast Reconstruction market as follows:
By Technology
By Type
By Placement
By Procedure
By Geography